The European Medicines Agency warns that Novo Nordisk's Ozempic and Wegovy may, in rare cases, cause NAION—a serious eye condition that can lead to vision loss. The EMA has asked the company to update ...

Rapper Badshah recently took to X (formerly Twitter) to post a simple message, "Dua Lipa (red heart emoji)," while it seemed ...

Rumour has it Karan Johar secretly flew to South Korea multiple times to get… his face insured. Yup, inspired by a close friend, and apparently it’s a trend there. Insiders say he’s been way more ...

Spread This News By Staff Reporter  THE Medicines Control Authority of Zimbabwe (MCAZ) and the Health Professions Authority ...

After working with a string of top-flight directors like Francis Ford Coppola and Quentin Tarantino , she suffered an ...

Mr. Funk was the managing editor of Pleroma Media, and worked as a breaking news reporter at The Messenger after spending 25 ...

In the past, studies in type-2 diabetes patients have linked Ozempic to the condition called non-arteritic anterior ischemic ...

Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

So, what's the tea on microdosing? It's pretty much what it sounds like — taking smaller doses than the usual prescribed ...